Skip to main content
Avivagen Inc. logo

Avivagen Inc. — Investor Relations & Filings

Ticker · VIV ISIN · CA05382F2026 TSXV Manufacturing
Open in API
Filings indexed 552 across all filing types
Latest filing 2020-09-03 Earnings Release
Country CA Canada
Listing TSXV VIV

About Avivagen Inc.

http://www.avivagen.com

Avivagen Inc. was a life sciences corporation focused on developing and commercializing natural health products for livestock, companion animals, and humans. The company specialized in feed additives designed to support immune function and promote growth in animals, emphasizing science-based validation through clinical trials. On April 23, 2024, Avivagen Inc. filed a voluntary assignment in bankruptcy, and a trustee was appointed to manage the proceedings.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Earnings Release Classification · 95% confidence The document is a press release announcing Avivagen Inc.'s unaudited financial results for the third quarter ending July 31, 2020. It includes specific financial figures for the quarter, such as revenue amounts and comparisons to previous periods, as well as commentary from the CEO about business performance and outlook. The document is not a full quarterly report but an initial announcement of quarterly financial results with key highlights. It does not contain comprehensive financial statements or detailed analysis typical of an Interim/Quarterly Report (IR). It is also not an Annual Report, Audit Report, or any other detailed filing. Therefore, the document fits the definition of an Earnings Release (ER), which is the initial announcement of quarterly financial results with key highlights. Q3 2020
2020-09-03 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a FORM 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate, signed by the CFO, certifying the review and fair presentation of the interim financial report and interim MD&A for the period ended July 31, 2020. It explicitly states it is a certification letter and does not contain the actual interim financial data or analysis itself. According to the Certification Rule, such officer certifications or attestations, even if referencing interim reports, should be classified as Regulatory Filings (RNS) rather than the interim report itself. The document length is short (2999 characters), consistent with a certification letter rather than a full report. Therefore, the correct classification is Regulatory Filings (RNS).
2020-09-02 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a certification by the CEO of Avivagen Inc. regarding the interim financial report and interim MD&A for the period ended July 31, 2020. It is a Form 52-109FV2, which is a certification of interim filings for a venture issuer. The text explicitly states it is a certification and does not contain the actual interim financial data or MD&A content, but rather attests to their accuracy and fair presentation. According to the Certification Rule, documents that are primarily officer certifications or attestations, even if referencing interim reports, should be classified as Regulatory Filings (RNS). The document length is short (2997 characters), and it is clearly a certification letter, not the interim report itself.
2020-09-02 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Summary Financial Information and Management’s Discussion and Analysis of Financial Condition and Results of Operations' and includes detailed management discussion and analysis (MD&A) for the three- and nine-month periods ended July 31, 2020. It contains management responsibility statements, CEO and CFO certifications under National Instrument 52-109, and discusses financial condition, results of operations, liquidity, capital resources, and forward-looking statements. The document also references unaudited interim financial statements and is approximately 15,000 characters long, indicating it is a substantive report rather than a brief announcement or certification. The content and length align with an Interim / Quarterly Report (IR) which includes actual financial data and management analysis for a period shorter than a full fiscal year. Therefore, the appropriate classification is Interim / Quarterly Report (IR). 9M 2020
2020-09-02 English
Interim financial statements/report – English.pdf
Capital/Financing Update Classification · 95% confidence The document is titled 'Eighth Supplemental Indenture' and supplements an existing Indenture dated October 10, 2012. It provides detailed terms and conditions for the issuance of Medium Term Notes by Brookfield Infrastructure Finance entities. The content includes legal and financial provisions typical of debt indenture agreements, such as definitions, amendments, payment terms, covenants, and change of control clauses. This is a formal legal contract related to debt issuance and financing arrangements, not a financial report, earnings release, or regulatory announcement. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2020-09-02 English
News release - English.pdf
Regulatory Filings Classification · 90% confidence The document is a press release announcing the publication of a scientific paper in the British Journal of Nutrition. It discusses the content and significance of the paper, provides a link to the publication, and includes forward-looking statements and company background information. There is no financial data, regulatory filing, or report attached or summarized. The document is not an annual report, interim report, earnings release, or any other financial or regulatory filing. It is an announcement related to scientific research publication, which does not fit into the specific financial or regulatory categories. Therefore, the best fit is Regulatory Filings (RNS) as a general announcement that does not fit other categories.
2020-08-18 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.